Top News

Apr 23, 2015
BioPharm International
Originator product manufacturers will have to update and improve their processing platforms to stay competitive with the biosimilars coming to market.
Apr 23, 2015
BioPharm International
Prequalified manufacturing suites could benefit from a new business model, say some industry executives.
Apr 22, 2015
BioPharm International
By BioPharm International Editors
INTERPHEX 2015 is under way and Pharmaceutical Technology and BioPharm International are in the middle of the action!
Apr 17, 2015
BioPharm International
Glatopa is the first generic version of Copaxone.
Apr 14, 2015
BioPharm International
Spending on prescription medications reached $373.9 billion in 2014, representing the largest increase in 13 years.
Apr 10, 2015
BioPharm International
The grants will be offered to investigators conducting research in the field of PCSK9 biology.
Apr 08, 2015
By BioPharm International Editors
Mylan announces that it would offer Perrigo $29 billion in cash and stock to buy the Irish company.
Apr 07, 2015
BioPharm International
Novartis will make payments to Juno to settle a patent dispute covering chimeric antigen receptor T-cell (CAR-T) therapies.
Apr 02, 2015
By BioPharm International Editors
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
Apr 01, 2015
By BioPharm International Editors
USP announces an implementation date of Jan. 1, 2018 for General Chapters <232> Elemental Impurities—Limits and <2232> Elemental Contaminants in Dietary Supplements.
native1_300x100
lorem ipsum